The key takeaway is that the potential benefits of GLP-1 therapy may extend beyond the number on the scale, says study author Amy Sheer, MD, MPH, an associate professor of internal medicine at the University of Florida College of Medicine in Gainesville
The dosing regimen often involves one injection per week, as it has a prolonged half-life (due to the DAC component)
To reach more people, we need non-opioid based treatment options with easy initiation and improved side effect profiles, like GLP-1s and non-addictive painkillers
The increasing prevalence of obesity worldwide and its associated pressure on healthcare systems, along with the reputation of GLP-1 drugs for inducing significant weight loss (approximately 1525+%, significantly higher than previous generations of obesity drugs), are driving GLP-1 drug expansion into new markets like China
We propose that long-term extra sugar intake multiple times a day can gradually sweep the -cells away, and suggest that simultaneously taking glutathione, an antioxidant, in each meal could prevent blood glucose/ROS-induced detrimental effects on -cell
